These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12556735)

  • 1. Improving perioperative outcomes in patients with end-stage heart failure.
    Nussmeier NA
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S29-34. PubMed ID: 12556735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical therapy of end-stage heart failure. State of the art 2006].
    Klotz S; Loeher A; Drees G; Scheld HH
    Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
    Bove T; Landoni G; Calabrò MG; Aletti G; Marino G; Cerchierini E; Crescenzi G; Zangrillo A
    Circulation; 2005 Jun; 111(24):3230-5. PubMed ID: 15967861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy.
    Cooper JR; Abrams J; Frazier OH; Radovancevic R; Radovancevic B; Bracey AW; Kindo MJ; Gregoric ID
    J Thorac Cardiovasc Surg; 2006 May; 131(5):963-8. PubMed ID: 16678576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
    Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
    Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients.
    Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S35-40. PubMed ID: 12556736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
    Barr LF; Kolodner K
    Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to transplantation in the surgical therapy for heart failure.
    Nicolini F; Gherli T
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):214-28. PubMed ID: 19091591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of refractory heart failure with a percutaneous circulatory support device.
    Mammana C; Tespili M; Costalunga A; Jacovoni A; Veritti U; Lorini L; Ferrazzi P; Gavazzi A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):443-7. PubMed ID: 16721210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternative approaches in the end-stage heart failure].
    Durdu S; Akar R; Cavolli R; Eren NT; Corapçioğlu T; Uçanok K; Ozyurda U
    Anadolu Kardiyol Derg; 2003 Sep; 3(3):252-60. PubMed ID: 12967894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanical assist devices in advanced heart failure. Indications and perspectives].
    Colombo T; Russo C; Lanfranconi M; Bruschi G; Garatti A; Milazzo F; Catena E; Oliva F; Turazza F; Frigerio M; Vitali E
    G Ital Cardiol (Rome); 2006 Feb; 7(2):91-108. PubMed ID: 16532721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surgical treatment of end-stage heart failure.
    Blom AS; Acker MA
    Curr Probl Cardiol; 2007 Oct; 32(10):553-99. PubMed ID: 17920924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total artificial heart--concepts and clinical use.
    Morris RJ
    Semin Thorac Cardiovasc Surg; 2008; 20(3):247-54. PubMed ID: 19038735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the MicroMed DeBakey VAD for the treatment of end-stage heart failure.
    DeBakey ME; Teitel ER
    Expert Rev Med Devices; 2005 Mar; 2(2):137-40. PubMed ID: 16293049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in heart failure treatment and heart transplantation.
    Augoustides JG; Riha H
    J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):738-48. PubMed ID: 19686962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.